Latin America Genitourinary Drugs Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$1,770.4

Forecast, 2030 (US$M)

$1,911.2

CAGR, 2024 - 2030

1.1%

Report Coverage

Latin America

Latin America genitourinary drugs market, 2018-2030 (US$M)

Related Markets

Global Genitourinary Drugs Industry Outlook

North America Genitourinary Drugs Market Outlook

Europe Genitourinary Drugs Market Outlook

Asia Pacific Genitourinary Drugs Market Outlook

MEA Genitourinary Drugs Market Outlook

Latin America genitourinary drugs market highlights

The Latin America genitourinary drugs market generated a revenue of USD 1,770.4 million in 2023.
The market is expected to grow at a CAGR of 1.1% from 2024 to 2030.
In terms of segment, prostate cancer was the largest revenue generating indication in 2023.
Prostate cancer is the most lucrative indication segment registering the fastest growth during the forecast period.

Latin America data book summary

Market revenue in 2023	USD 1,770.4 million
Market revenue in 2030	USD 1,911.2 million
Growth rate	1.1% (CAGR from 2023 to 2030)
Largest segment	Prostate cancer
Fastest growing segment	Prostate cancer
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Prostate cancer
Key market players worldwide	Abbott Laboratories, Bristol-Myers Squibb Co, Novartis AG ADR, Genentech, Roche, Ionis Pharmaceuticals Inc, Eli Lilly and Co, Merck KGaA, Pfizer Inc, AstraZeneca PLC, GlaxoSmithKline, Teva Pharmaceutical Industries Ltd, Bayer AG, Allergan

Other key industry trends

In terms of revenue, Latin America region accounted for 6.0% of the global genitourinary drugs market in 2023.
Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 10,495.6 million by 2030.

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Genitourinary Drugs Market Scope

Genitourinary drugs market segmentation & scope

Indication

Prostate cancer

Ovarian cancer

Bladder cancer

Cervical cancer

Renal cancer

Erectile dysfunction

Urinary tract infections

Urinary incontinence & overactive bladder

Sexually transmitted diseases

Interstitial cystitis

Hematuria

Benign prostatic hyperplasia

Product

Urologicals

Hormonal therapy drugs

Gynecological

Anti-infectives

Others

Regions

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Countries

U.S.

Canada

Germany

France

Italy

Spain

Switzerland

Netherlands

Denmark

Sweden

Norway

Japan

China

India

Australia

South Korea

Indonesia

Thailand

Mexico

Brazil

South Africa

Saudi Arabia

Argentina

Kuwait

UAE

Genitourinary Drugs Market Companies

Name	Profile	# Employees	HQ	Website

Latin America genitourinary drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genitourinary drugs market will help companies and investors design strategic landscapes.

Prostate cancer was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Latin America genitourinary drugs market based on prostate cancer covering the revenue growth of each sub-segment from 2018 to 2030.

Reasons to subscribe to Latin America genitourinary drugs market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America genitourinary drugs market databook

Our clientele includes a mix of genitourinary drugs market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America genitourinary drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America genitourinary drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list